By Brian M. Reiser Many investors are wondering if Equillium Inc. (Nasdaq: EQ) stock is a buy right now. Equillium is a biotechnology company that specializes in products for severe autoimmune and inflammatory disorders. And the biotech industry is certainly a hot one these days, thanks to the recent deployment of millions of COVID-19 vaccines.
Wall Street analysts are bullish on this stock, largely on the strength of clinical trials for its anti-CD6 monoclonal antibody, Itolizumab. Successful trials could lead to strong long-term growth.
In this article, we will take a closer look at Equillium stock. Should investors be optimistic about the future? If so, Equillium …read more
